Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Therapeutic Advances in Drug Safety

• Publication date

  2018-05-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/2042098618772979PMID 29854391PMCID PMC5971403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antidepressant Use Among Persons Aged 12 and Over:United States,2011-2014.

  2017cited by this paper
• Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study.

  2016cited by this paper
• Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.

  2015cited by this paper
• Assessing Prolongation of the Heart Rate Corrected QT Interval in Users of Tricyclic Antidepressants: Advice to Use Fridericia Rather Than Bazett’s Correction

  2015cited by this paper
• American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

  2015cited by this paper
• Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010

  2015cited by this paper
• The Measurement of the QT Interval

  2014cited by this paper
• Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

  2014cited by this paper
• QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.

  2014cited by this paper
• Use of tricyclic antidepressants as analgesic adjuvants results in nonhazardous prolongation of the QTc interval.

  2014cited by this paper
• Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.

  2014cited by this paper
• Validation of a population‐based method to assess drug‐induced alterations in the QT interval: a self‐controlled crossover study

  2013cited by this paper
• Datapoints: Prevalence of QT prolongation among veterans with severe mental illness.

  2013cited by this paper
• Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.

  2011cited by this paper
• A study on electrocardiographic changes secondary to the use of tricyclic antidepressants in patients with chronic pain.

  2009cited by this paper
• Psychotropic Drugs Associated With Corrected QT Interval Prolongation

  2009cited by this paper
• The QT interval: too long, too short or just right.

  2009cited by this paper
• Sudden death in patients receiving drugs tending to prolong the QT interval.

  2009cited by this paper
• Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive Disorder

  2008cited by this paper
• Citalopram induced torsade de pointes, a rare life threatening side effect.

  2008cited by this paper
• Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.

  2006cited by this paper
• QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine.

  2006cited by this paper
• QT interval prolongation associated with venlafaxine administration.

  2006cited by this paper
• Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

  2006cited by this paper
• Torsade de pointes

  2003cited by this paper
• Risk stratification in the long-QT syndrome.

  2003cited by this paper
• Evaluation of Drug-Induced QT Interval Prolongation

  2001cited by this paper
• Selective Serotonin Reuptake Inhibitors for Late-Life Depression

  2001cited by this paper
• Tricyclic neuroleptic and antidepressant overdose: epidemiological, electrocardiographic, and clinical features--a survey of 92 cases.

  1990cited by this paper
• Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed.

  1989cited by this paper
• Comparison of the effects of bupropion and amitriptyline on cardiac conduction in depressed patients.

  1983cited by this paper

• Personalized Approach to Prediction and Prevention Clozapine-Induced QT Prolongation

  2025cites this paper
• Heart Rate-Corrected QT Interval Dynamics Following Antidepressant Switching from Escitalopram to High-Dose Venlafaxine: Cardiac Safety Insights from the Early Medication Change Cohort

  2025cites this paper
• Assessment and Management of Neuropathic Pain in Primary Care and Resource-limited Setting: The Indonesian Perspective

  2025cites this paper
• Antidepressants and sexual health – How to improve patients’ quality of life?

  2025cites this paper
• Electrocardiographic Abnormalities in Elderly Patients Receiving Psychotropic Therapy in the Emergency Department: A Retrospective Cohort Study

  2025cites this paper
• Validation of a Clinical Decision Support Tool for Quantifying Risk of Torsades de Pointes in a Psychiatric Inpatient Population.

  2025cites this paper
• Psychosocial and clinical characteristics in Takotsubo syndrome

  2025cites this paper
• Single-Substance SSRI Intoxication: A Clinical and Outcome Profile Presentation in a Poisoning Referal Center

  2025cites this paper
• Surveillance of Corrected QT Interval-Prolonging Medications upon Admission throughout Hospitalization in a Tertiary Care Geriatric Ward

  2025cites this paper
• Antipsychotic-Induced QT Prolongation and Torsade de Pointes in Patients with Mental Disorders: A Review

  2024cites this paper
• Identification and Management of Medical Comorbidities in Patients With HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Literature Review and Recommendations From Experts in Spain Opinion.

  2024cites this paper
• What is the Evidence for Using Antidepressants to Reduce Anxiety for People with Dementia?

  2024cites this paper
• Preoperative management of medications for psychiatric disorders.

  2024cites this paper
• Adverse effects of trazodone in dogs on primary hemostasis and electrocardiogram: A single‐blinded placebo‐controlled crossover study

  2023cites this paper
• Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study

  2023cites this paper
• Impact of Hydroxychloroquine, on QTC Interval, in Patients with Rheumatologic Diseases

  2023cites this paper
• Role of Pharmacokinetics and Pharmacogenetics of Antidepressant-Induced Prolongation of the QT Interval and Torsade de Pointes in Patients with Mental Disorders

  2023cites this paper
• Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trial

  2023cites this paper
• Inhibitory Effectiveness in Delayed-Rectifier Potassium Current Caused by Vortioxetine, Known to Be a Novel Antidepressant

  2022cites this paper
• A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults

  2022cites this paper
• Antidepressant‐induced serotonin syndrome in older patients: a cross‐sectional study

  2022cites this paper
• METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF FLUPENTIXOL AND ESCITALOPRAM BY USING RP-HPLC

  2022cites this paper
• SIMULTANEOUS DETERMINATION OF FLUPENTIXOL AND NORTRIPTYLINE HCl USING RP-HPLC WITH PDA DETECTOR

  2022cites this paper
• Comparison of Clinical Manifestations of Patients Poisoned with Tricyclic Antidepressants Alone or with Benzodiazepine Intoxication According to the Dose of Benzodiazepines

  2022cites this paper
• Non-Cardiac Medications Induced QT Prolongation in Cardiac patients: A Retrospective Analysis

  2022cites this paper
• Determinação do risco potencial de interações medicamentosas prolongadoras do intervalo QT em idosos internados em unidade de terapia intensiva

  2022cites this paper
• Antidepressants

  2021cites this paper
• Congenital long QT syndrome: a clinician's guide

  2021cites this paper
• Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review

  2021cites this paper
• The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review.

  2021cites this paper
• Evaluating the risk of QTc prolongation associated with hydroxychloroquine use with antidepressants in lupus patients with fibromyalgia

  2021cites this paper
• Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study

  2021cites this paper
• Psychological and pharmacological interventions for depression in patients with coronary artery disease.

  2021cites this paper
• First Report of Coronary Vasospasm with Sertraline in Children.

  2021cites this paper
• Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review

  2021cites this paper
• Second generation antidepressants and the risk of arrhythmia

  2021cites this paper
• Hydroxychloroquine and Potential Drug Interactions in Older Adults

  2020cites this paper
• Screening for atrial fibrillation and other arrhythmias in primary care

  2020cites this paper
• SSRIs: An Update for Home Care Clinicians.

  2020cites this paper
• Cardiovascular side effects of neuropsychiatric medication: an update

  2020cites this paper
• ADDI: Recommending alternatives for drug-drug interactions with negative health effects

  2020cites this paper
• Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

  2020cites this paper
• Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence

  2020cites this paper
• Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome

  2019cites this paper
• The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

  2019cites this paper
• Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

  2019cites this paper
• Safety Implications of Low-Dose Amitriptyline in Neuropathic Pain

  2019cites this paper
• Top Ten Tips Palliative Care Clinicians Should Know About Psychopharmacology

  2019cites this paper
• Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

  2019cites this paper
• NDT_A_235669 3599..3607

  2019cites this paper
• How do you choose the appropriate migraine pharmacotherapy for an elderly person?

  2018cites this paper
• A Novel Stability‑Indicating Method for Determination of Related Substances of Viloxazine Hydrochloride in a Active Pharmaceutical Ingredient (API) form Using RP‑HPLC

  year unknowncites this paper
• EVALUATION OF PATIENTS AT RISK OF DRUG-INDUCED QT INTERVAL PROLONGATION AND SUBSEQUENT DEVELOPMENT OF TORSADES DE POINTES

  year unknowncites this paper